Form 4 for MAIA MAIA Biotechnology, Inc.
Accepted 2022-08-25 00:00:00 ET · period of report 2022-08-24 · accession 0000899243-22-029752 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-25 | 2022-08-24 | MAIA | Gryaznov Sergei | CSO | M - OptEx | $1.80 | +10.0K | 34.5K | +41% | +$18.0K |
| D | 2022-08-25 | 2022-08-24 | MAIA | Gryaznov Sergei | CSO | M - OptEx | $0.00 | -10.0K | 48.0K | -17% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-24 | M | A | 10,000 | $1.80 | 34,511 | D | — | — | |
| 2 | Derivative | Stock Options | 2022-08-24 | M | D | 10,000 | $0.00 | 48,000 | D | $1.80 · — to 2029-11-30 | 10,000 Common Stock | (F1) Represents the right to buy shares of Common Stock granted pursuant to the 2018 Stock Option Plan. These options vested in four equal monthly installments beginning on December 1, 2019. |